PBAC nominations invited
AMA members are invited to nominate to a specialist position on the Pharmaceutical Benefits Advisory Committee (PBAC).
This is a challenging and stimulating position that provides the opportunity to contribute directly to pharmaceutical benefits policy in Australia.
PBAC is an independent expert committee that advises the Minister for Health on medicines in relation to the Pharmaceutical Benefits Scheme. PBAC is required to consider the clinical effectiveness, safety and cost effectiveness of a medication compared with existing therapies. Members must be able to interpret the comparative outcomes of therapy involving a drug and appraise evidence.
The AMA has been asked to nominate a range of potential candidates, particularly those with expertise in epidemiology. The AMA’s Federal Executive Council will assess nominations prior to forwarding them to the Minister for potential appointment.
PBAC meets for three, three/four-day meetings a year and may hold up to three additional one-day meetings. PBAC members currently receive an annual salary of $36,750 and all travel costs are reimbursed. Appointments are for four years.
Further information about PBAC can be found on the DoHA website at www.health.gov.au.
To nominate, please forward a curriculum vitae no longer than 2 pages (Click here [system/files/sample_cv.pdf] for an example) to email@example.com by Tuesday, 20 August 2013. If you have any questions, please contact Georgia Morris on 02 6270 5466.